|
|
|
|
β2-adrenoceptor
|
|
|
Hs |
Antagonist |
Antagonist |
8.4 |
pA2 |
- |
10 |
|
| ⤷ |
pA2
8.4
[10]
|
|
β3-adrenoceptor
|
|
|
Hs |
Antagonist |
Partial agonist |
7.2 |
pA2 |
- |
10 |
|
| ⤷ |
pA2
7.2
[10]
|
|
β2-adrenoceptor
|
|
|
Hs |
Antagonist |
Antagonist |
8.1 – 9.3 |
pKi |
- |
5-7,10 |
|
| ⤷ |
pKi
8.1 – 9.3
[5-7,10]
|
|
β2-adrenoceptor
|
|
|
Hs |
Agonist |
Partial agonist |
7.2 – 9.3 |
pKi |
- |
5-8,10 |
|
| ⤷ |
pKi
7.2 – 9.3
[5-8,10]
|
|
β3-adrenoceptor
|
|
|
Mm |
Antagonist |
Partial agonist |
8.0 – 8.3 |
pKi |
- |
9 |
|
| ⤷ |
pKi
8.0 – 8.3
[9]
|
|
β1-adrenoceptor
|
|
|
Hs |
Antagonist |
Partial agonist |
7.4 – 8.4 |
pKi |
- |
3,5-7,10 |
|
| ⤷ |
pKi
7.4 – 8.4
[3,5-7,10]
|
|
β3-adrenoceptor
|
|
|
Hs |
Antagonist |
Partial agonist |
6.9 – 8.4 |
pKi |
- |
4-5,7-8,10 |
|
| ⤷ |
pKi
6.9 – 8.4
[4-5,7-8,10]
|
|
β1-adrenoceptor
|
|
|
Hs |
Agonist |
Partial agonist |
7.5 |
pKi |
- |
3,5-7 |
|
| ⤷ |
pKi
7.5
[3,5-7]
|
|
β3-adrenoceptor
|
|
|
Hs |
Agonist |
Partial agonist |
6.9 – 7.4 |
pKi |
- |
4-5,8,10 |
|
| ⤷ |
pKi
6.9 – 7.4
[4-5,8,10]
|
|
β2-adrenoceptor
|
|
|
Hs |
Agonist |
Partial agonist |
8.1 – 8.4 |
pEC50 |
- |
5-6,10 |
|
| ⤷ |
pEC50
8.1 – 8.4
[5-6,10]
|
|
β1-adrenoceptor
|
|
|
Hs |
Agonist |
Partial agonist |
7.3 – 8.2 |
pEC50 |
- |
2,5-6,10 |
|
| ⤷ |
pEC50
7.3 – 8.2
[2,5-6,10]
|
|
β3-adrenoceptor
|
|
|
Hs |
Agonist |
Partial agonist |
6.5 – 7.6 |
pEC50 |
- |
1,5,10 |
|
| ⤷ |
pEC50
6.5 – 7.6
[1,5,10]
|
|